CELLMUNE 500MG

Cellmune 500mg Tablet is an immunosuppressant that contains Mycophenolate mofetil as its active ingredient. It falls under the category of inosine monophosphate dehydrogenase (IMPDH) inhibitors. This medication is utilized to prevent organ rejection in patients who have undergone organ transplants, such as kidney, heart, or liver transplants. It is typically prescribed as part of a combination therapy alongside other immunosuppressive agents.

This medication is contraindicated during pregnancy due to the potential for birth defects and miscarriage. It should only be prescribed to pregnant women if there are no suitable alternatives and the benefits significantly outweigh the risks. Women of childbearing age are strongly advised to use effective contraception while taking this tablet to avoid pregnancy. Live vaccines should not be given to individuals taking Cellmune 500mg Tablet, as it may diminish vaccine efficacy and increase the risk of infection. Patients on this medication should refrain from donating blood during treatment and for at least six weeks after discontinuation to ensure the drug is fully eliminated from their system before blood donation.

It is generally recommended to avoid this medication if you have an allergy to it or any of its components. Notify your healthcare provider if you have liver or heart conditions before starting treatment. Since this drug suppresses the immune system, it may elevate the risk of skin cancer. Patients should take measures to minimize their exposure to sunlight and ultraviolet (UV) radiation. Contact your doctor immediately if you experience any bruising, fever, unexplained fatigue, dizziness, jaundice, vision changes, decreased urine output, or seizures after taking this medication. Cellmune 500mg Tablet is an immunosuppressive drug that may impact the developing immune system of an infant and should be avoided during breastfeeding. In certain situations, alternative medications with a better safety profile for breastfeeding may be considered.